The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake

Brain Research

Volumn 1306, Issue , 2010, Pages 85-92

  Pritchett, Carolyn E ^a   Pardee, Alicia L ^b   McGuirk, Sophia R ^b   Will, Matthew J ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Adenosine; CCPA; CGS 21680; DAMGO; Feeding; High fat; MSX 3; Nucleus accumbens; Palatable food

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; NALTREXONE; NEUROTRANSMITTER; OPIATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN RADIOGRAPHY; CONTROLLED STUDY; FOOD INTAKE; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 71549155300     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.115     Document Type: Article

References (46)

1. Ammon-Treiber S., and Höllt V. Morphine-induced changes of gene expression in the brain. Addict. Bio. 10 (2005) 81-89
2. Antoniou K., Papadopoulou-Daifoti Z., Hyphantis T., Papathanasiou G., Bekris E., Marselos M., Panlilio L., Muller C.E., Goldberg S.R., and Ferré S. A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology 183 (2005) 154-162
3. Baldo B.A., and Kelley A.E. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology 191 (2007) 439
4. Barbano M.F., and Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191 (2007) 497-506
5. Barraco R.A., Martens K.A., Parizon M., and Normile H.J. Role of adenosine A2a receptors in the nucleus accumbens. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 (1993) 545-553
6. Brundege J.M., and Williams J.T. Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J. Neurophys. 87 (2002) 1369-1375
7. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87 (2007) 659-797
8. Cabeza de Vaca S., Kannan P., Pan Y., Jiang N., Sun Y., and Carr K.D. The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats. Brain Res. 1142 (2007) 100-109
9. Coupar I.M., and Tran B.L. Effects of adenosine agonists on consumptive behaviour and body temperature. J. Pharm. Pharmacol. 54 (2002) 289-294
10. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27 (1985) 63-139
11. Farrar A.M., Pereira F., Velasco F., Hockemeyer J., Müller C.E., and Salamone J.D. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology 191 (2007) 579-586
12. Ferré S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology 133 (1997) 107-120
13. Ferré S. Heteromerization of G-protein-coupled receptors. Implications for central nervous system function and dysfunction. Sci. World J. 7 (2007) 46-47
14. Ferré S., Ciruela F., Quiroz C., Lujan R., Popoli P., Cunha R.A., Agnati L.F., Fuxe K., Woods A.S., Lluis C., and Franco R. Adenosine receptor heteromers and their integrative role in striatal function. Sci. World J. 7 (2007) 74-85
15. Font L., Mingote S., Farrar A.M., Pereira M., Worden L., Stopper C., Port R.G., and Salamone J.D. Intra-accumbens injections of the adenosine A(2A) agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology 199 (2008) 515-526
16. Franco R., Lluis C., Canela E.I., Mallol J., Agnati L., Casadó V., Ciruela F., Ferré S., and Fuxe K. Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J. Neural. Transm. 114 (2007) 93-104
17. Halimi G., Devaux C., Clot-Faybesse O., Sampol J., Legof L., and Rochat H.G. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur. J. Pharmacol. 398 (2000) 217-224
18. Hauber W., and Münkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol. 323 (1997) 127-131
19. Ishiwari K., Madson L.J., Farrar A.M., Mingote S.M., Valenta J.P., DiGianvittorio M.D., Frank L.E., Correa M., Hockemeyer J., Muller C., and Salamone J.D. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Behav. Brain Res. 178 (2007) 190-199
20. Karcz-Kubicha M., Antoniou K., Terasmaa A., Quarta D., Solinas M., Justinova Z., Pezzola A., Reggio R., Müller C.E., Fuxe K., Goldberg S.R., Popoli R., and Ferré S. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28 (2003) 1281-1291
21. Kaplan G.B., and Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur. J. Pharmacol. 362 (1998) 1-8
22. Kaplan G.B., and Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology 123 (1996) 64-70
23. Khan G.M., Smolders I., Ebinger G., and Michoette Y. 2-Chloro-N6-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats. Neuropharmacology 40 (2001) 657-667
24. Kelley A.E., Bakshi V.P., Fleming S., and Holahan M.R. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens. Neuropsychopharmacology 23 (2000) 455-467
25. Kelley A.E., Baldo B.A., Pratt W.E., and Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav. 86 (2005) 773-795
26. Levine A.S., and Morley J.E. Effect of intraventricular adenosine on food intake in rats. Pharmacol. Biochem. Behav. 19 (1983) 23-26
27. Levine A.S., Grace M., Krahn D.D., and Billington C.J. The adenosine agonist N6-R-phenylisopropyladenosine (R-PIA) stimulates feeding in rats. Brain Res. 477 (1989) 280-285
28. MacDonald A.F., Billington C.J., and Levine A.S. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res. 1018 (2004) 78-85
29. Nagel J., Schladebach H., Koch M., Schwienbacher I., Müller C.E., and Hauber W. Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats. Synapse 49 (2003) 279-286
30. Okada M., Mizuno K., and Kaneko S. Adenosine A1 and A2A receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212 (1996) 53-56
31. Olszewski P.K., and Levine A.S. Central opioids and consumption of sweet tastants: When reward outweighs homeostasis. Physiol. Behav. 90 (2007) 506-512
32. Ongini E., and Fredholm B.B. Pharmacology of adenosine A2A receptors. Trends Pharmacol. Sci. 10 (1996) 364-372
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.) (1998), Academic Press, New York
34. Pecina S., and Berridge K.C. Opioid site in nucleus accumbens shell mediates eating and hedonic "liking" for food: map based on microinjection Fos plumes. Brain Res. 863 (2000) 71-86
35. Quarta D., Borycz J., Solina M., Patkar K., Hockemeyer J., Circuela F., Lluis C., Franco F., Woods A., Goldberg S., and Ferre S. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J. Neurochem. 91 (2004) 873-880
36. Salem A., and Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 57 (1997) 671-679
37. Schiffmann S.N., Jacobs O., and Vanderhaeghen J.J. Striatal restricted adenosine A2 Receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An In Situ hybridization histochemistry study. J. Neurochem. 57 (1991) 1062-1067
38. Schiffmann S.N., Fisone G., Moresco R., Cunha R.A., and Ferré S. Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 83 (2007) 277-292
39. Schwienbacher I., Fendt M., Hauber W., and Koch M. Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition. Eur. J. Pharmacol. 444 (2002) 161-169
40. Wager-Srdar S., Levine A.S., and Morley J.E. Food intake: opioid/purine interactions. Pharmacol. Biochem. Behav. 21 (1984) 33-38
41. Will M.J., Pratt W.E., and Kelley A.E. Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum. Physiol. Behav. 89 (2006) 226-234
42. Will M.J., Pritchett C.E., Parker K.E., Sawani A.M., Ma H., and Lai A.L. Behavioral characterization of amygdala involvement in mediating intra-accumbens opioid-driven feeding behavior. Behav. Neuro. 123 (2009) 781-793
43. Woolley J.D., Lee B.S., and Fields H.L. Nucleus accumbens opioids regulate flavor-based preferences in food consumption. Neuroscience 143 (2006) 309-317
44. Worden L.T., Shahriari M., Farrar A.M., Sink K.S., Hockemeyer J., Müller C.E., and Salamone J.D. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology 203 3 (2009) 489-499
45. Yao L., McFarland K., Fan P., Jiang Z., Ueda T., and Diamond I. Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc. Natl. Acad. Sci. 103 (2006) 7877-7882
46. Zhang M., Gosnell B.A., and Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J. Pharmacol. Exp. Ther. 285 (1998) 908-914